Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
ABP0074 Dexamethasone causes calcium deposition and degeneration in human anterior cruciate ligament cells through endoplasmic reticulum stress(ABP0074-4.42) 4.42 Biochemical Pharmacology
ABP0083 E-cadherin Polyclonal Antibody Artemisinin induced reversal of EMT affects the molecular biological activity of ovarian cancer SKOV3 cell lines(ABP0083-1.84) 1.84 Oncology letters
ABP0148 Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo(ABP0148-6.88) 6.88 Pharmaceutica Sinica B
ABP50019 Armillariella Oral Solution Ameliorates Small Intestinal Damage in a Mouse Model of Chemotherapy-Induced Mucositis(ABP50019-2.44) 2.44 Nutr Cancer
ABP50139 Pharmacological activation of the Nrf2 pathway by 3H-1, 2-dithiole-3-thione is neuroprotective in a mouse model of Alzheimer disease(ABP50139-3.16) 3.16 Behav Brain Res
ABP50151 7‑Difluoromethyl‑5, 4'‑dimethoxygenistein exerts anti‑angiogenic effects on acute promyelocytic leukemia HL‑60 cells by inhibiting the TLR4/NF‑κB signaling pathway(ABP50151-1.97) 1.97 Molecular Medicine Reports
ABP50152 Effect of endostatin on proliferation, invasion and epithelial-mesenchymal transition of basal cell carcinoma cell A431(ABP50152-2.387) 2.387 European Review for Medical and Pharmacological Sciences
ABP50223 Effect of endostatin on proliferation, invasion and epithelial-mesenchymal transition of basal cell carcinoma cell A431(ABP50223-2.387) 2.387 European Review for Medical and Pharmacological Sciences
ABP50257 MicroRNA-374 Exerts Protective Effects by Inhibiting SP1 Through Activating the PI5K/Akt Pathway in Rat Models of Myocardial Ischemia-Reperfusion After Sevoflurane Preconditioning(ABP50257-4.81) 4.81 Cellular Physiology and Biochemistry.
Abp50262 miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(Abp50262-4.29) 4.29 Scientific Reports